James Greenwald
Internal Medicine · New York, NYNPI 1366992737
Payments from drug & device makers
Across 1,406 payments — averaging $3511.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$2.8M
- Eli Lilly$743K
- Modernatx, Inc.$563K
- Alnylam Pharmaceuticals Inc.$446K
- AstraZeneca$182K
- Sanofi US Services Inc.$96K
- plus $120K from 6 others
Across 2 payments — averaging $49,318 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$99K
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 135 | $2,786,590 |
| Eli Lilly | 17 | $742,972 |
| Modernatx, Inc. | 44 | $563,355 |
| Alnylam Pharmaceuticals Inc. | 1,079 | $446,100 |
| AstraZeneca | 8 | $182,460 |
| Sanofi US Services Inc. | 16 | $96,214 |
| Esperion Therapeutics, Inc. | 88 | $57,478 |
| GSK | 5 | $36,796 |
| Chiesi USA, Inc. | 1 | $11,000 |
| Noven Pharmaceuticals, Inc. | 11 | $9,716 |
| Novartis | 1 | $5,000 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $25 |
How this compares
$4,937,706 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in New York
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- Sally LauNew York$8.4M
- Maria RubinsteinNew York$6.3M
- Dana RathkopfNew York$6M
- Eytan SteinNew York$5.8M
- Claire FriedmanNew York$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.